Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors
- PMID: 10884069
- DOI: 10.1097/00001756-200006260-00048
Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors
Abstract
Targeting regulatable transgene expression specifically to neuronal or glial cell populations would facilitate studies of CNS gene function. We have developed the tetracycline (Tet) regulatable adenoviral system by expressing the Tet-off transactivator (tTA) under the control of the neuronal-specific synapsin I promoter and the well characterized glial-specific glial fibrillary acidic protein (GFAP) promoter. Transfection of primary hippocampal cultures demonstrated that the respective promoters restricted reporter transgene expression exclusively to neuronal or glial populations. Delivery of the vectors into adult rat hippocampus resulted in a similar pattern of cell specific transgene expression. These novel vectors provide a highly effective means of directing regulated, cell-specific, transgene expression and as such are important tools for investigations of neuronal and glial cell function and advancing gene therapy studies.
Similar articles
-
Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer.J Gene Med. 2005 May;7(5):576-83. doi: 10.1002/jgm.694. J Gene Med. 2005. PMID: 15580589
-
Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression.Mol Ther. 2000 Dec;2(6):579-87. doi: 10.1006/mthe.2000.0215. Mol Ther. 2000. PMID: 11124058
-
In vivo transgene expression using an adenoviral tetracycline-regulated system with neuron-specific enolase promoter.Biochem Biophys Res Commun. 2004 May 14;317(4):1144-8. doi: 10.1016/j.bbrc.2004.03.166. Biochem Biophys Res Commun. 2004. PMID: 15094388
-
Optimizing regulatable gene expression using adenoviral vectors.Exp Physiol. 2005 Jan;90(1):33-7. doi: 10.1113/expphysiol.2004.028209. Epub 2004 Nov 12. Exp Physiol. 2005. PMID: 15542617 Review.
-
Regulatable and cell-type specific transgene expression in glial cells: prospects for gene therapy for neurological disorders.Prog Brain Res. 2001;132:655-81. doi: 10.1016/S0079-6123(01)32109-X. Prog Brain Res. 2001. PMID: 11545027 Review. No abstract available.
Cited by
-
Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.Neuron Glia Biol. 2006 Nov;2(4):309-22. doi: 10.1017/S1740925X07000579. Neuron Glia Biol. 2006. PMID: 18084640 Free PMC article.
-
Characterization of inducible models of Tay-Sachs and related disease.PLoS Genet. 2012 Sep;8(9):e1002943. doi: 10.1371/journal.pgen.1002943. Epub 2012 Sep 20. PLoS Genet. 2012. PMID: 23028353 Free PMC article.
-
Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).Cell Biol Toxicol. 2010 Feb;26(1):1-20. doi: 10.1007/s10565-009-9139-5. Epub 2009 Oct 15. Cell Biol Toxicol. 2010. PMID: 19830583 Free PMC article.
-
Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.J Gene Med. 2008 May;10(5):583-92. doi: 10.1002/jgm.1178. J Gene Med. 2008. PMID: 18324737 Free PMC article.
-
Transcriptional Targeting in Cancer Gene Therapy.J Biomed Biotechnol. 2003;2003(2):110-137. doi: 10.1155/S1110724303209074. J Biomed Biotechnol. 2003. PMID: 12721516 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous